All Stories

  1. Genomic and transcriptomic profiling of pre‐ and postneoadjuvant chemotherapy triple negative breast cancer tumors
  2. Stearate-rich diet and oleate restriction directly inhibit tumor growth via the unfolded protein respons
  3. Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis
  4. Cellular senescence triggers intracellular acidification and lysosomal pH alkalinized via ATP6AP2 attenuation in breast cancer cells
  5. Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: Propensity score matching and inverse probability of treatment weighting analysis
  6. Tumor immune microenvironment and systemic response in breast cancer
  7. Serum amyloid alpha 1-2 are not required for systemic inflammation in the 4T1 murine breast cancer model
  8. Subcategory classifications of Breast Imaging and Data System (BI-RADS) category 4 lesions on MRI
  9. Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy
  10. DNA damage repair functions and targeted treatment in breast cancer
  11. Alteration of specific cytokine expression patterns in patients with breast cancer
  12. Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients
  13. Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
  14. Targeting CXCR4-dependent immunosuppressive Ly6C low monocytes improves antiangiogenic therapy in colorectal cancer
  15. Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity
  16. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer
  17. Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer
  18. Assessing the effects of neoadjuvant chemotherapy on lymphatic pathways to sentinel lymph nodes in cases of breast cancer: Usefulness of the indocyanine green-fluorescence method
  19. Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients
  20. Antipsychotics-Containing Regimen As an Alternative to Standard Antiemetics for Delayed Nausea Induced by Highly Emetogenic Chemotherapy
  21. Correlation between docetaxel-induced skin toxicity and the use of steroids and H2 blockers: a multi-institution survey